U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Substance Class Protein
Created
by admin
on Wed Apr 02 16:52:02 GMT 2025
Edited
by admin
on Wed Apr 02 16:52:02 GMT 2025
Protein Type BISPECIFIC ANTIBODY
Protein Sub Type IGG4|KAPPA
Sequence Origin HUMANIZED MOUSE
Sequence Type COMPLETE
Record UNII
M55KSH2AGH
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
Lucorafusp Alfa
Common Name English
AK-130
Preferred Name English
gamma 4 heavy chain (1-447) [VH (Homo sapiens IGHV4-30-4*01 -(IGHD) -IGHJ4*01, CDR-Kabat [6.16.12] (31-36.51-66.99-110)) (1-121) -Homo sapiens IGHG4*01 (CH1 (122-219), hinge S<sup>229</sup>>P (220-231), CH2 F<sup>235</sup>>A, L<sup>236</sup>>A (232-341),
Common Name English
Immunoglobulin G4 [229-proline,235-alanine,236-alanine,476-threonine,de-468-lysine], anti-(human receptor TIGIT) (human-Mus musculus monoclonal AK130 ?4-chain) fusion protein with peptide linker ((GGGGS)4G) fusion protein with 2-137-transforming growth f
Common Name English
humanized immunoglobulin G4-kappa, anti-[human TIGIT (T cell immunoreceptor with Ig domain and ITIM, V-set Ig member 9, VSIG9, V-set and transmembrane member 3, VSTM3)] fused at the C-terminus of the heavy chain, via a (G4S)4 peptide linker, to a fragmen
Common Name English
lucorafusp alfa [INN]
Common Name English
AK130
Code English
Code System Code Type Description
CAS
2769742-99-4
Created by admin on Wed Apr 02 16:52:02 GMT 2025 , Edited by admin on Wed Apr 02 16:52:02 GMT 2025
PRIMARY
INN
12728
Created by admin on Wed Apr 02 16:52:02 GMT 2025 , Edited by admin on Wed Apr 02 16:52:02 GMT 2025
PRIMARY
NCI_THESAURUS
C198990
Created by admin on Wed Apr 02 16:52:02 GMT 2025 , Edited by admin on Wed Apr 02 16:52:02 GMT 2025
PRIMARY
FDA UNII
M55KSH2AGH
Created by admin on Wed Apr 02 16:52:02 GMT 2025 , Edited by admin on Wed Apr 02 16:52:02 GMT 2025
PRIMARY
SMS_ID
300000054753
Created by admin on Wed Apr 02 16:52:02 GMT 2025 , Edited by admin on Wed Apr 02 16:52:02 GMT 2025
PRIMARY
From To
4_134 4_194
4_23 4_88
3_134 3_194
3_23 3_88
1_230 2_230
1_227 2_227
2_135 4_214
1_135 3_214
2_583 2_588
2_566 2_581
2_522 2_546
2_506 2_512
2_499 2_516
2_496 2_529
2_368 2_426
2_262 2_322
2_148 2_204
2_22 2_96
1_583 1_588
1_566 1_581
1_522 1_546
1_506 1_512
1_499 1_516
1_496 1_529
1_368 1_426
1_262 1_322
1_148 1_204
1_22 1_96
Glycosylation Type MAMMALIAN
Glycosylation Link Type Site
N 1_298
N 1_515
N 1_539
N 2_298
N 2_515
N 2_539
Related Record Type Details
ACTIVE MOIETY
immunomodulator, antineoplastic
Name Property Type Amount Referenced Substance Defining Parameters References
Molecular Formula CHEMICAL
MOL_WEIGHT:NUMBER(CALCULATED) CHEMICAL